Koers EI- Nile Co. for Pharmaceuticals and Chemical Industries
Aandelen
NIPH
EGS38331C012
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
68,75 EGP | 0,00% |
|
0,00% | -17,27% |
Omzet 2022 | 877 mln. 18,4 mln. 17,14 mln. | Omzet 2023 | 1,01 mld. 21,09 mln. 19,65 mln. | Marktkapitalisatie | 405 mln. 8,5 mln. 7,91 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 89 mln. 1,87 mln. 1,74 mln. | Nettowinst (verlies) 2023 | 119 mln. 2,5 mln. 2,33 mln. | EV/omzet 2022 | 0,44 x |
Nettoschuld 2022 | 26,21 mln. 550K 512K | Nettoschuld 2023 | 191 mln. 4,01 mln. 3,73 mln. | EV/omzet 2023 | 0,59 x |
K/w-verhouding 2022 |
4
x | K/w-verhouding 2023 |
3,4
x | Werknemers | - |
Dividendrendement 2022 |
8,38% | Dividendrendement 2023 |
12,5% | Vrij verhandelbaar | 21,83% |
3 maanden | -22,10% | ||
6 maanden | -18,97% | ||
Lopend jaar | -17,27% |
![Extreem 67](/images/extremecours_fleche.png)
![Extreem 67](/images/extremecours_fleche.png)
![Extreem 67](/images/extremecours_fleche.png)
![Extreem 37](/images/extremecours_fleche.png)
![Extreem 24](/images/extremecours_fleche.png)
![Extreem 15.7](/images/extremecours_fleche.png)
![Extreem 7.72](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | - | |
Director of Finance/CFO | - | - | |
Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | - | - | |
Chairman | - | - | |
Director/Board Member | - | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
13-06-24 | 68,75 | 0,00% | 3 598 |
12-06-24 | 68,75 | 0,00% | 30 |
11-06-24 | 68,75 | 0,00% | 1 356 |
10-06-24 | 68,75 | 0,00% | 106 |
slotkoers Egyptian Exchange, 13 juni 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-17,27% | 14,59 mln. | |
+51,82% | 797 mld. | |
+39,87% | 628 mld. | |
+16,95% | 323 mld. | |
+9,49% | 300 mld. | |
+16,62% | 244 mld. | |
+0,45% | 223 mld. | |
+9,45% | 214 mld. | |
+5,30% | 163 mld. | |
-6,29% | 153 mld. |